APA

Johnston S. R., Kilburn L. S., Ellis P., Dodwell D., Cameron D., Hayward L., Im Y., Braybrooke J. P., Brunt A. M., Cheung K., Jyothirmayi R., Robinson A., Wardley A. M., Wheatley D., Howell A., Coombes G., Sergenson N., Sin H., Folkerd E., Dowsett M. & Bliss J. M. (20131104). Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial. : The Lancet. Oncology.

Chicago

Johnston Stephen Rd, Kilburn Lucy S, Ellis Paul, Dodwell David, Cameron David, Hayward Larry, Im Young-Hyuck, Braybrooke Jeremy P, Brunt A Murray, Cheung Kwok-Leung, Jyothirmayi Rema, Robinson Anne, Wardley Andrew M, Wheatley Duncan, Howell Anthony, Coombes Gill, Sergenson Nicole, Sin Hui-Jung, Folkerd Elizabeth, Dowsett Mitch and Bliss Judith M. 20131104. Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial. : The Lancet. Oncology.

Harvard

Johnston S. R., Kilburn L. S., Ellis P., Dodwell D., Cameron D., Hayward L., Im Y., Braybrooke J. P., Brunt A. M., Cheung K., Jyothirmayi R., Robinson A., Wardley A. M., Wheatley D., Howell A., Coombes G., Sergenson N., Sin H., Folkerd E., Dowsett M. and Bliss J. M. (20131104). Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial. : The Lancet. Oncology.

MLA

Johnston Stephen Rd, Kilburn Lucy S, Ellis Paul, Dodwell David, Cameron David, Hayward Larry, Im Young-Hyuck, Braybrooke Jeremy P, Brunt A Murray, Cheung Kwok-Leung, Jyothirmayi Rema, Robinson Anne, Wardley Andrew M, Wheatley Duncan, Howell Anthony, Coombes Gill, Sergenson Nicole, Sin Hui-Jung, Folkerd Elizabeth, Dowsett Mitch and Bliss Judith M. Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial. : The Lancet. Oncology. 20131104.